VELCADE^® (bortezomib) for Injection is indicated for the treatment of patients with multiple myeloma.

VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron, or mannitol.

For further information about VELCADE and Multiple Myeloma (MM), select a menu item in the list to the left.

Please CLICK HERE to view important safety information.

For full Prescribing Information CLICK HERE. (PDF)

For further information about VELCADE^® (bortezomib) for Injection,
call 1-866-VELCADE (U.S. clinicians only).